Transcatheter Pulmonary Valve Market Size, Share, Trends and Forecast Report 2023-2028

IMARC Group, a leading market research company, has recently releases report titled “Transcatheter Pulmonary Valve Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” The study provides a detailed analysis of the industry, including the global transcatheter pulmonary valve market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Report Highlights:

How big is the transcatheter pulmonary valve market?

The global transcatheter pulmonary valve market size reached US$ 80.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 137.91 Million by 2028, exhibiting a growth rate (CAGR) of 9.23% during 2023-2028.

What are the growth prospects and trends in the transcatheter pulmonary valve industry?

The global transcatheter pulmonary valve market is primarily driven by the increasing prevalence of congenital heart diseases. Additionally, the rising demand for less invasive treatment options such as transcatheter pulmonary valves is contributing to the market growth. TPVs eliminate the need for a large incision and cardiopulmonary bypass, leading to reduced operative risks, shorter hospital stays, and quicker recovery times for patients. Moreover, several technological advancements in TPV and the introduction of several devices providing optimal performance, precise placement, and long-term durability represent other major growth-inducing factors. Besides this, the rising shift toward personalized treatment approaches, customization, and patient-specific solutions with advanced TPVs is accelerating the product adoption rate. Also, the growing focus on pediatric cardiology and the expanding application of TPVs in pediatric cases offers significant advantages, including reduced trauma, improved growth potential, and avoidance of multiple open-heart surgeries as the child grows are driving market expansion.

Request for a sample copy of this report: https://www.imarcgroup.com/transcatheter-pulmonary-valve-market/requestsample

What is Transcatheter Pulmonary Valve?

The transcatheter pulmonary valve (TPV) is a groundbreaking medical device that revolutionizes the treatment of congenital heart defects and other pulmonary valve disorders. It is generally produced from biocompatible materials and can be expanded or deployed within the native pulmonary valve position, restoring proper blood flow and alleviating symptoms. It is also a minimally invasive (MI) alternative to traditional open-heart surgery, allowing for the replacement or repair of the pulmonary valve through a catheter-based procedure. Additionally, transcatheter pulmonary valves are designed to replace or repair malfunctioning pulmonary valves and offer reduced hospital stay, less scarring, improved quality of life, and minimally invasive procedures.

What is included in market segmentation?

The report has segmented the market into the following categories:

Market Breakup by Technology:

• Balloon-Expanded Transcatheter Valve
• Self-Expanded Transcatheter Valve

Market Breakup by Raw Material:

• Tissue Engineered
• Synthetic

Market Breakup by Application:

• Tetralogy of Fallot
• Cardiac Anomaly
• Pulmonary Atresia
• Pulmonary Stenosis
• Pulmonary Regurgitation
• Truncus Arteriosus
• Others

Market Breakup by End User:

• Adult
• Pediatric

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

• Abbott Laboratories
• Artivion Inc.
• Boston Scientific Corporation
• Braile Biomédica
• Colibri Heart Valve LLC
• Edwards Lifesciences Corporation
• JenaValve Technology Inc.
• Labcor Laboratórios Ltda.
• Medtronic plc
• Venus Medtech (Hangzhou) Inc

Browse the full report with TOC & List of Figures: https://www.imarcgroup.com/transcatheter-pulmonary-valve-market

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Email: sales@imarcgroup.com

Follow us on Twitter: @imarcglobal

LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/

Article source: https://article-realm.com/article/Health-Fitness/48235-Transcatheter-Pulmonary-Valve-Market-Size-Share-Trends-and-Forecast-Report-2023-2028.html